Caris Life Sciences, Inc.
CAI
$18.26
-$0.21-1.14%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | ||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1,107.19% | -- | -- | -72.51% | |
| Total Receivables | 27.08% | -- | -- | -- | |
| Inventory | 60.78% | -- | -- | -- | |
| Prepaid Expenses | 44.42% | -- | -- | -- | |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | |
| Other Current Assets | -52.68% | -- | -- | -- | |
| Total Current Assets | 362.52% | -- | -- | -- | |
|
|
|||||
| Total Current Assets | 362.52% | -- | -- | -- | |
| Net Property, Plant & Equipment | 0.24% | -- | -- | -- | |
| Long-term Investments | 0.00% | -- | -- | -- | |
| Goodwill | 0.00% | -- | -- | -- | |
| Total Other Intangibles | -- | -- | -- | -- | |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | |
| Total Other Assets | -6.67% | -- | -- | -- | |
| Total Assets | 227.48% | -- | -- | -- | |
|
|
|||||
| Total Accounts Payable | 41.07% | -- | -- | -- | |
| Total Accrued Expenses | -11.05% | -- | -- | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Current | -90.13% | -- | -- | -- | |
| Total Finance Division Other Current Liabilities | 227.87% | -- | -- | -- | |
| Total Other Current Liabilities | 227.87% | -- | -- | -- | |
| Total Current Liabilities | -23.14% | -- | -- | -- | |
|
|
|||||
| Total Current Liabilities | -23.14% | -- | -- | -- | |
| Long-Term Debt | 18.56% | -- | -- | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Capital Leases | 9.81% | -- | -- | -- | |
| Finance Division Debt Non Current | -- | -- | -- | -- | |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | |
| Total Other Liabilities | -99.95% | -- | -- | -- | |
| Total Liabilities | -11.69% | -- | -- | -- | |
|
|
|||||
| Common Stock & APIC | 8,268,328.95% | -- | -- | -- | |
| Retained Earnings | -3.09% | -- | -- | -- | |
| Treasury Stock & Other | 39.95% | -- | -- | -- | |
| Total Common Equity | 123.10% | -- | -- | -21.21% | |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | |
| Preferred Stock Convertible | -- | -- | -- | -- | |
| Preferred Stock, Others | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | 5.69% | |
|
|
|||||
| Total Common Equity | 123.10% | -- | -- | -21.21% | |
| Total Preferred Equity | -- | -- | -- | 5.69% | |
| Total Minority Interest | -- | -- | -- | -- | |
| Total Equity | 308.27% | -- | -- | -1,698.80% | |
|
|
|||||